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Introduction: Pseudotumor cerebri secondary to all-trans retinoic acid in acute promyelocytic leukemia is a
reported but rare complication of the therapy. Most cases improve following the discontinuation of all-trans retinoic
acid. There is no published literature on how to manage such patients if severe symptoms of increased intracranial
pressure continue after discontinuation of the drug.
Case presentation: We report the case of a 16-year-old Afro-Caribbean woman with aggressive secondary
pseudotumor cerebri who presented to our facility with visual failure that persisted despite discontinuation of all-trans
retinoic acid. A lumbar drain was inserted for 11 days resulting in symptomatic relief of headaches and objective
improvement of visual failure. Pressure settings were titrated regularly to ensure optimal symptomatic relief.
Conclusions: The use of a lumbar drain for continuous drainage of cerebrospinal fluid in patients with all-trans retinoic
acid-induced pseudotumor cerebri resistant to all-trans retinoic acid discontinuation is a feasible management option.
This method can be used when other less invasive measures have failed to improve signs and symptoms. Permanent
drainage of cerebrospinal fluid with a shunt may also provide a long-term viable management strategy but the use of
a lumbar drain may be preferable if the cause of pseudotumor cerebri is known to be self-limiting.Introduction
Acute promyelocytic leukemia (APL) is a distinct subset
of acute myeloid leukemia characterized by an abnormal
fusion protein promyelocytic locus gene (PML)/retinoic
acid receptor α (RARA) [1]. All-trans retinoic acid
(ATRA) is a common treatment for APL. It degrades the
PML/RARA fusion protein causing terminal differenti-
ation of malignant cells in the bone marrow as indicated
by the presence of Auer rods [2]. This is followed by the
re-emergence of normal hematopoietic cells as patients
achieve complete remission. ATRA is associated with a
high incidence of complete remission in patients newly
diagnosed as having APL [3]. Pseudotumor cerebri is a
rare but well described side effect of ATRA therapy in
patients with APL, most commonly children [4,5]. It is
characterized by headache, nausea and/or vomiting,
papilledema and diplopia. We present a case of pseudo-
tumor cerebri that was resistant to normal therapies,
which only resolved when a previously unreported inter-
vention (insertion of a lumbar drain) was employed.* Correspondence: fahidrasul@doctors.org.uk
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A 16-year-old Afro-Caribbean woman was diagnosed as
having APL and given ATRA. Three weeks later she pre-
sented to our emergency department with severe headache
and visual loss. This was thought to be secondary to ATRA
treatment. Serum analysis and diagnostic lumbar puncture
(LP) were performed confirming the absence of other
causes. ATRA was discontinued. Symptoms of increased
intracranial pressure persisted despite discontinuation of
the drug.
Intrathecal cytarabine was administered twice per
week and a total of five cycles were given over a
period of 18 days. The papilledema remained stable
during this period. Dexamethasone was also given. Six
lumbar punctures were performed over this 18-day
period. The opening pressures ranged from 28cmH20
to 43cmH20. Between 30 and 50mL of cerebrospinal
fluid (CSF) was drained on each occasion. Unfortu-
nately headaches and visual loss persisted despite
these interventions. Computed tomography (CT) im-
aging of the brain on day 18 showed mildly reduced
size ventricles with moderate effacement of cortical
subarachnoid spaces. Secondary pseudotumor cerebrid. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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specialized neurosurgical unit for further care.
A lumbar drain was inserted under sedation at the L3/4
level for continuous drainage of CSF. A 20G needle was
used with our patient lying in the fetal position and the
bevel facing upwards to ensure accurate measurement of
opening and closing pressures. The opening pressure was
noted to be 37cmH20. Neuro-ophthalmological assess-
ment confirmed swollen discs consistent with severe papil-
ledema at the time of lumbar drain insertion. Our patient
remained in bed rest for 11 days. The pressure setting on
the lumbar drain was adjusted according to our patient’s
signs and symptoms. Pressure settings ranged from
5cmH20 to 10cmH20 to ensure optimal CSF drainage.
Pressures as high as 26cmH20 were observed during the
lumbar drain phase. Daily neuro-ophthalmology review
showed significant improvement in papilledema over the
11-day period for which the lumbar drain remained in situ.
On the day of admission to the neurosurgical unit the vis-
ual acuity of our patient was recorded as CF1 (counting
fingers at 1 foot distance) in the right eye and CF10 in the
left eye. On day seven the visual acuity was recorded as 6/
60 in the right eye and 6/24 in the left eye. On day 11,
prior to removal, visual acuity was 6/18 in the right eye
and 6/12 in the left eye. Visual field charts on day 11 are
shown in Figure 1. The marked improvement in papille-
dema and visual acuity over a short period is unusual and
is discussed further in the discussion section. Gradual
symptomatic improvement occurred over the first seven
days. The drain was removed four days later when the
pressure had stabilized at 12cmH20 level. After removal
of the drain our patient experienced low-pressure head-
aches for three days. These were self-limiting and hadFigure 1 Visual field charts prior to removal of lumbar drain.disappeared two days prior to discharge. Our patient suf-
fered no subsequent symptoms and signs of increased
intracranial pressure and remained well at three-month
follow-up.
Discussion
Acute promyelocytic leukemia (APL) is a distinct subset
of acute myeloid leukemia. It represents five percent of all
acute myeloid leukemia’s. It is characterized by abnormal,
heavily granulated promyelocytes. The precise pathophy-
siology is unknown. However it has been speculated that
an excess of vitamin A enhances production of CSF and
alters the lipid constituents of arachnoid villi causing
impaired absorption of CSF [6]. ATRA is commonly used
to treat patients with APL. It provides a better complete
remission rate compared to chemotherapy alone [3]. Pseu-
dotumor cerebri is a recognized but rare complication
in APL. It is characterized by signs and symptoms of
increased intracranial pressure, no signs of hydrocephalus
on brain imaging and a high opening pressure on lumbar
puncture. Early diagnosis is important to ensure appropri-
ate therapy is administered to prevent persistent visual
impairment and even blindness [7].
Several cases of pseudotumor cerebri secondary to
ATRA therapy have been described. There is conflicting
evidence for the need to discontinue ATRA treatment in
patients with recognized pseudotumor cerebri secondary
to the drug. It has been postulated that the effect of ATRA
diminishes with time due to pharmacological adaptation
resulting in reduced serum concentration after prolonged
treatment [8]. Some reports have suggested that ATRA-
induced pseudotumor cerebri is self-limiting while others
have suggested improvement only on discontinuation of
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for more than three weeks after discontinuation.
It is likely that the drug can give rise to a spectrum of
severity of raised intracranial pressure ranging from a
mild self-limiting disorder to one that is severe and per-
sistent, as was the case with our patient, with a real risk
of blindness.
Only rarely is there a need for drainage of CSF for
symptomatic improvement. To the best of our know-
ledge, we present the first case in which pseudotumor
cerebri persisted despite discontinuation of ATRA and
serial therapeutic lumbar punctures.
It has been reported that promyelocytic leukemia is
associated with venous sinus thrombosis [11]. Further-
more dural venous sinus thrombosis is a recognized
cause of pseudotumor cerebri [12]. It is therefore possible
that the observed pseudotumor cerebri was caused by ven-
ous sinus thrombosis. A CT venogram is the investigation
of choice for the diagnosis of venous sinus thrombosis and
allows physicians to start anti-coagulation therapy in the
form of a heparin infusion or treatment dose low molecu-
lar weight heparin if the investigation is positively diagnos-
tic. In our patient’s case this investigation was not
performed, however, we suggest that this could be an add-
itional diagnostic tool that may be utilized giving another
alternative treatment if found to be positive for venous
sinus thrombosis. There have been some case series sug-
gesting that venous sinus stenting is an effective treatment
for pseudotumor cerebri [13]. However, currently it is not
a widely used treatment modality in the UK. The time
course of improvement observed in our patient is consist-
ent with recanalization of a dural venous sinus after
thrombosis. The lumbar drain exerts its effect by reducing
intracranial pressure (ICP). Our patient showed signifi-
cant improvement in their symptoms of raised ICP as
we titrated the lumbar drain settings to symptomatic
effect. If the primary cause for pseudotumor cerebri
was venous sinus thrombosis the treatment with a
lumbar drain was useful in improving our patient’s
symptoms over the period it took for recanalization of the
venous sinus. The time course for recanalization is unpre-
dictable and therefore repeated lumbar punctures is not
recommended while awaiting recanalization due to the
repeated exposure to the risks and complications of this
procedure. This may explain the rapid improvement in
papilledema. CSF diversion via a lumbar drain is not
known to improve papilledema so rapidly, although optic
nerve sheath fenestration has a much more rapid action. It
is possible that the lumbar drain allowed recanalization of
a venous sinus, which caused a rapid improvement of
papilledema. In this way the lumbar drain ‘broke the cycle’
of pseudotumor cerebri.
On insertion of a lumbar drain we were able to titrate the
pressures to ensure adequate drainage of CSF to improveour patient’s signs and symptoms. Additional measures
that could be used if this approach did not provide a long-
term solution would include the insertion of a shunt for
permanent CSF diversion. This is commonly used in
patients with pseudotumor cerebri of other etiologies. In
this situation a CT venogram would be more useful as it
may confirm or exclude venous sinus thrombosis as the
primary cause. This may affect management as a dural
sinus stent may be considered as an alternative, permanent
treatment in persistent cases although this procedure is
only performed in select centers currently.
Conclusions
In pseudotumor cerebri secondary to ATRA in patients
with APL, placement of a lumbar drain is a viable ma-
nagement strategy until signs and symptoms of increased
intracranial pressure improve. It is an invasive low risk
surgical procedure. Pressure can be titrated to suit the
patient’s signs and symptoms. Other, more long-term
interventions may include permanent CSF diversion via a
shunt. Careful consideration should be made to investigate
the etiology of this rare condition in individuals if this will
affect management decisions.
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